Shih-Hung Yang Jen-Chieh Lee Bang-Bin Chen Sung-Hsin Kuo Chiun Hsu Li-Yuan Bai
10.3389/fimmu.2022.870406
Front Immunol
2022 Apr 28;13:870406.
case report chemotherapy maintenance therapy nivolumab pancreatic ductal adenocarcinoma
CC BY
https://pubmed.ncbi.nlm.nih.gov/35572526/
Adenocarcinoma / drug therapy Adenocarcinoma / secondary Carcinoma, Pancreatic Ductal / drug therapy Pancreatic Neoplasms / drug therapy Pancreatic Neoplasms / pathology
Adenocarcinoma / drug therapy Adenocarcinoma / secondary Carcinoma, Pancreatic Ductal / drug therapy Pancreatic Neoplasms / drug therapy Pancreatic Neoplasms / pathology Case Reports Research Support, Non-U.S. Gov't Humans Male Middle Aged Nivolumab / adverse effects Nivolumab Pancreatic Carcinoma
PMC9097224
35572526
Case Report: Maintenance Nivolumab in Complete Responder After Multimodality Therapy in Metastatic Pancreatic Adenocarcinoma
2022